CDC Raises Alarm About Meningitis Threat to Patients Visiting Mexican Surgical Clinics

THURSDAY, June 8, 2023 (HealthDay News) -- U.S. health officials are urgently trying to reach people who have recently had medical procedures at clinics in Matamoros, Mexico, because they may be at risk of potentially fatal fungal meningitis.
Those at risk had procedures done under epidural anesthesia between Jan. 1 and May 13 at River Side Surgical Center and Clinica K-3 in Matamoros, Tamaulipas, the U.S. Centers for Disease Control and Prevention said Tuesday.
As of June 1, 14 people in the United States had been identified with these suspected infections, 11 with probable infections, and two with confirmed infections. Among them, three died. Another 185 people in the United States may have been exposed, according to an agency news release. Patients could be in danger even if they do not have symptoms or have mild symptoms, and they should seek immediate medical treatment, the CDC noted.
The CDC sounded the alarm after several U.S. laboratories and the Mexican national laboratory (InDRE) detected the fungus Fusarium solani species complex in the spinal fluid of some patients receiving follow-up care in Mexico or the United States after procedures at the clinic.
Public health officials also strongly encouraged health care providers to assess any patient, with or without symptoms, who had procedures at these clinics. This includes assessment with MRI and a lumbar puncture collecting cerebrospinal fluid (CSF). The priority should be obtaining CSF for testing.
Health departments and others are encouraged to raise awareness about the outbreak, even if no one in their area has been identified as at risk.
Related Posts
¿Las luces de la ciudad significan más picaduras de mosquito?
MIÉRCOLES, 12 de abril de 2023 (HealthDay News) -- Parece que la luz nocturna...
Using Devices as Babysitters Can Backfire on Parents
MONDAY, Dec. 12, 2022 (HealthDay News) -- It's an all-too-familiar scenario for...
Excess AMI-Linked Mortality Persisted During Pandemic
WEDNESDAY, Oct. 26, 2022 (HealthDay News) -- Excess acute myocardial infarction...
WHO Guideline Advises Against Fluvoxamine, Colchicine for COVID-19
FRIDAY, July 15, 2022 (HealthDay News) -- Fluvoxamine and colchicine are not...